Human skin culture as an ex vivo model for assessing the fibrotic effects of insulin-like growth factor binding proteins
about
Fibroblasts in fibrosis: novel roles and mediatorsSimultaneous deactivation of FAK and Src improves the pathology of hypertrophic scarDecreased caveolin-1 levels contribute to fibrosis and deposition of extracellular IGFBP-5.Syndecan-2 is a novel target of insulin-like growth factor binding protein-3 and is over-expressed in fibrosis.The membrane-associated adaptor protein DOK5 is upregulated in systemic sclerosis and associated with IGFBP-5-induced fibrosis.IGFBP-5 Promotes Fibrosis Independently of Its Translocation to the Nucleus and Its Interaction with Nucleolin and IGF.Estradiol promotes the development of a fibrotic phenotype and is increased in the serum of patients with systemic sclerosisAdipose tissue-derived stem cells suppress hypertrophic scar fibrosis via the p38/MAPK signaling pathway.A peptide derived from endostatin ameliorates organ fibrosis.Development of an ex vivo human skin model for intradermal vaccination: tissue viability and Langerhans cell behaviour.Cdc42 inhibits ERK-mediated collagenase-1 (MMP-1) expression in collagen-activated human keratinocytes.Insulin-like growth factor binding proteins-3 and -5: central mediators of fibrosis and promising new therapeutic targets.MRP1 knockdown down-regulates the deposition of collagen and leads to a reduced hypertrophic scar fibrosis.The fibrotic phenotype induced by IGFBP-5 is regulated by MAPK activation and egr-1-dependent and -independent mechanisms.Tissue Inhibitor of Metalloproteinase-2 Suppresses Collagen Synthesis in Cultured Keloid Fibroblasts.IGFBP-5 Promotes Fibrosis via Increasing Its Own Expression and That of Other Pro-fibrotic Mediators
P2860
Q26998508-6B440D1F-E0ED-4586-A806-1681E5D29BFBQ28834206-07DD4FF4-144A-4EF7-8CC2-A5AF87D53A5FQ34367785-651F8914-4820-4B7F-B461-5F32023760F7Q34382756-BAD6A643-0B4E-4A6A-A90B-8A25953C0007Q35097280-3772AF31-EC69-4367-98E6-B55ADBE66B79Q35672107-A98358F2-381F-409D-B8EE-409D06F4AFC3Q36903132-FDF4941B-AEB9-418C-B451-867B78207662Q37145666-548ACEC8-0878-48C9-B67D-080F2E3D4C74Q37340061-B1D76C9B-E881-48E7-9A49-95802983AEECQ37366646-AB36368D-A116-43A9-8792-77821587AAF8Q37707170-E15D6178-09D1-47E8-9CA3-C006EF87E442Q38026844-F5344C0F-AA8B-4299-ADD3-CA204096BF4BQ38862010-18FA4328-DE06-4432-8BF0-E028CF61356BQ39821402-5BEE8006-D041-4135-A575-00A037BD9E6AQ41173697-4172550C-2F98-4EF8-BF35-06F8A88418AAQ58122025-F17D7C43-FD8C-4662-A201-544022FFB266
P2860
Human skin culture as an ex vivo model for assessing the fibrotic effects of insulin-like growth factor binding proteins
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Human skin culture as an ex vi ...... growth factor binding proteins
@en
type
label
Human skin culture as an ex vi ...... growth factor binding proteins
@en
prefLabel
Human skin culture as an ex vi ...... growth factor binding proteins
@en
P2093
P2860
P1476
Human skin culture as an ex vi ...... growth factor binding proteins
@en
P2093
Adriana T Larregina
Carol A Feghali-Bostwick
Hidekata Yasuoka
Yukie Yamaguchi
P2860
P356
10.2174/1874312900802010017
P577
2008-03-28T00:00:00Z